Home » Topics » BioWorld Science

BioWorld Science
RSS

EOLO-42016 shows promise in model of inherited ALS

Nov. 6, 2019

Investigators design mouse model of dwarfism with PCSK1 mutation

Nov. 6, 2019

NXP-031 leads to significant improvement of motor deficit in MPTP-induced mouse model of PD

Nov. 6, 2019

Daiichi Sankyo presents in vitro and in vivo data for DS-1039

Nov. 6, 2019

Regeneron provides updates on phase III development program of Libtayo in NSCLC

Nov. 6, 2019

Initiation of phase Ib study of mavorixafor in severe congenital neutropenia

Nov. 6, 2019

Further interim data presented from phase Ib study of EDP-1815 in patients with psoriasis

Nov. 6, 2019

eFFECTOR Therapeutics initiates early clinical study of zotatifin in advanced solid tumors

Nov. 6, 2019

Cartesian initiates phase I/II study of its lead CAR-T candidate, Descartes-08

Nov. 6, 2019

HLX-11 receives IND application acceptance notification from NMPA

Nov. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...